NDRA (ENDRA Life Sciences Inc.) Wutah bathi EPS kuartalan

endrainc.com - logo grafis emiten NDRA

The quarterly EPS evolution metric demonstrates the profit dynamics of ENDRA Life Sciences (NDRA), where the parameter value equals 106.60. The company's revenues are based on the implementation of TAEUS systems for affordable liver fat analysis. However, competition with ultrasound software manufacturers creates certain risks. At the same time, the brand's high reputation among radiologists supports optimism regarding the clinical potential of this technology.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan endrainc.com (NDRA): kanggo periode 04.07.2022 - 16.11.2026

Rincian metrik komprehensif lan analitis ENDRA Life Sciences (NDRA)

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analisis perusahaan:ENDRA Life Sciences
Produk asil prodhuksi ENDRA Corp

Institutional investors assess the attractiveness of ENDRA Life Sciences (NDRA) through net income dynamics, where stable cash flows confirm the efficiency of diversified medical equipment supply chains. By analyzing the quarterly EPS growth rate, which measures the rate of change in earnings per share relative to the previous period, one can identify the actual profitability of the business and eliminate the risk of manipulation via one-time write-offs.